Indian Pharma Takes Hedging Hit

  • 28 Apr 2008
Mumbai-based drugmaker Wockhardt posted an unexpected 23% fall in quarterly net profit caused by derivatives-related losses. A one-time mark-to-market charge of INR279 million were due to long-term hedging instruments bought to reduce loan interest costs. The hedging covered interest for 50% of its long-term loans.

Click here for ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 135,414.03 562 8.27%
2 Citi 128,055.36 503 7.82%
3 Bank of America Merrill Lynch 106,567.48 424 6.50%
4 Barclays 102,724.49 401 6.27%
5 Deutsche Bank 83,239.76 333 5.08%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 11,525.35 30 6.99%
2 UniCredit 8,872.38 48 5.38%
3 BNP Paribas 8,684.90 48 5.27%
4 Deutsche Bank 8,298.69 30 5.04%
5 Commerzbank Group 8,007.20 41 4.86%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Morgan Stanley 4,430.39 19 11.07%
2 Goldman Sachs 4,006.06 15 10.01%
3 Citi 3,572.77 22 8.93%
4 JPMorgan 2,809.08 19 7.02%
5 UBS 2,281.21 12 5.70%